真实世界临床数据预测精神病临床高危人群长期不良结局:OASIS1000前瞻性研究
该研究基于英国OASIS服务2001至2024年的电子健康记录,纳入1000例精神病临床高危(CHR-P)患者,开发并内部验证预测长期不良结局的临床模型。14至18年累积不良结局风险为0.644(95%CI:0.547-0.742),模型区分度C=0.69(95%CI:0.63-0.74),提示多数CHR-P患者存在超越精神病转变的长期不良结局。
要点
- CHR-P患者14至18年真实世界不良结局累积风险达0.644,远超短期精神病转变。
- 基于常规诊疗数据的预测模型区分度C=0.69,在0%至50%风险阈值下净获益优于临床替代方案。
- CHR-P服务应延长照护时间,以应对年轻患者显著的长期临床结局。
核心结论
- 多数CHR-P个体在真实世界照护中存在超越精神病转变的长期不良结局,应成为新一代研究焦点。
- 所开发的临床预测模型可识别高风险个体,支持个性化预防性照护的提供。
研究设计与样本
- RECORD合规的真实世界长期前瞻性队列研究,纳入英国南伦敦OASIS服务2001至2024年全部CHR-P患者的电子健康记录。
- 共纳入1000例CHR-P患者,平均年龄22.51±4.99岁,53.60%为男性,44.73%为白人,随访最长21年。
- 采用正则化Cox回归开发临床预测模型,并以内部-外部交叉验证进行验证。
主要发现
- 真实世界不良结局14至18年累积风险为0.644(95%CI:0.547-0.742)。
- 模型区分度Harrell's C=0.69(95%CI:0.63-0.74),校准斜率1.61(95%CI:0.74-2.48)、截距-0.03(95%CI:-0.62至0.55)。
- 整体表现Brier评分为0.18(95%CI:0.13-0.22)。
- 决策曲线分析显示,在0%至50%风险阈值下模型净获益大于临床替代方案。
关键数值与推荐
- 主要结局为首次真实世界不良结局的长期累积风险,包括转变为精神病、接受首剂抗精神病药治疗、首次自愿或强制精神科住院、或自杀死亡。
- 预测因子为常规照护中可获得的真实世界预测变量。
临床怎么用
- 临床可借助该模型在CHR-P常规照护中识别长期不良结局高风险个体,实现个性化预防性照护。
- CHR-P服务应考虑延长照护时长,以覆盖患者显著的长期临床结局。
局限性
- 研究基于单一OASIS服务的电子健康记录,模型仅进行内部-外部交叉验证,未报告外部独立验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most research into the clinical high risk for psychosis (CHR-P) state has focused on predicting transition to psychosis in the short term, and largely in research samples that are not representative of real-world preventive care. However, CHR-P individuals experience a broad range of poor long-term clinical outcomes in real-world settings, such as hospitalization for psychiatric reasons, initiation of a new antipsychotic treatment, or suicide. Improving the detection of individuals at greater risk of these long-term poor outcomes is critical to advance preventive care in real-world clinical settings. This study aims to develop and internally validate a personalized clinical prediction model for real-world, long-term poor outcomes beyond transition risk in CHR-P individuals. This RECORD-compliant, real-world, long-term prospective cohort study included electronic health records (EHR) data from all CHR-P individuals receiving preventive care from the Outreach and Support in South London (OASIS) service in South London and Maudsley National Health Service Foundation Trust in the UK from 2001 to 2024. The primary outcome was the long-term cumulative risk of first real-world poor outcome, operationalized by pragmatic parameters informing clinical practice: transition to psychosis, receiving a first antipsychotic treatment at a dosage necessary to treat first-episode psychosis, receiving a first voluntary or compulsory hospitalization for psychiatric reasons, or dying by suicide. A clinical prediction model (regularized Cox regression) was developed and validated using internal-external cross-validation to predict long-term poor outcomes, utilizing real-world predictors available in routine care. Model performance was indexed by discrimination (Harrell's C), calibration (slope, intercept), overall performance (Brier score), and potential clinical utility (decision curve analysis). One thousand CHR-P OASIS patients were included (mean age: 22.51±4.99 years; 53.60% males, 44.73% White) and followed up to a maximum of 21 years. The cumulative risk of real-world poor outcome was 0.644 (95% CI: 0.547-0.742) at 14-18 years. The validated clinical prediction model showed statistically significant discrimination (C=0.69; 95% CI: 0.63-0.74), calibration (slope = 1.61, 95% CI: 0.74-2.48; intercept = -0.03, 95% CI: -0.62 to 0.55) and overall performance (Brier score = 0.18; 95% CI: 0.13-0.22). Decision curve analysis demonstrated that the model was associated with greater net benefit than the clinical alternatives at risk thresholds from 0% to 50%. These data suggest that most CHR-P individuals have long-term poor outcomes, beyond transition to psychosis, in real-world care, which should become the focus of a new generation of research. The clinical prediction model presented here can identify these individuals and facilitate the personalized provision of preventive care, thereby improving outcomes in this population. CHR-P services should extend their duration of care to address the substantial long-term clinical outcomes experienced by young individuals.
引用
- Logeswaran Y, De Micheli A, Toniol I, et al. Predicting long-term poor outcomes in individuals at clinical high risk for psychosis using real-world clinical data: the OASIS1000 prospective study. World Psychiatry. 2026. PMID: 42136514. doi:10.1002/wps.70063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。